PT1666473E - Compostos ácido carboxílico e composições medicinais que os contêm como ingrediente activo - Google Patents
Compostos ácido carboxílico e composições medicinais que os contêm como ingrediente activoInfo
- Publication number
- PT1666473E PT1666473E PT47733738T PT04773373T PT1666473E PT 1666473 E PT1666473 E PT 1666473E PT 47733738 T PT47733738 T PT 47733738T PT 04773373 T PT04773373 T PT 04773373T PT 1666473 E PT1666473 E PT 1666473E
- Authority
- PT
- Portugal
- Prior art keywords
- carboxylic acid
- active ingredient
- same
- compositions containing
- acid compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/80—Radicals substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Otolaryngology (AREA)
- Child & Adolescent Psychology (AREA)
- Ophthalmology & Optometry (AREA)
- Nutrition Science (AREA)
- Vascular Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Obesity (AREA)
- Transplantation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003325198 | 2003-09-17 | ||
| JP2004101863 | 2004-03-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1666473E true PT1666473E (pt) | 2013-02-15 |
Family
ID=34380314
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT47733738T PT1666473E (pt) | 2003-09-17 | 2004-09-16 | Compostos ácido carboxílico e composições medicinais que os contêm como ingrediente activo |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US7601712B2 (pt) |
| EP (1) | EP1666473B1 (pt) |
| JP (1) | JP4919143B2 (pt) |
| KR (1) | KR20060080197A (pt) |
| AU (1) | AU2004274324B2 (pt) |
| BR (1) | BRPI0414487A (pt) |
| CA (1) | CA2539070C (pt) |
| DK (1) | DK1666473T3 (pt) |
| ES (1) | ES2399393T3 (pt) |
| IL (1) | IL174336A (pt) |
| MX (1) | MXPA06002945A (pt) |
| NO (1) | NO20061207L (pt) |
| NZ (1) | NZ545934A (pt) |
| PL (1) | PL1666473T3 (pt) |
| PT (1) | PT1666473E (pt) |
| RU (1) | RU2375353C2 (pt) |
| TW (1) | TWI341838B (pt) |
| WO (1) | WO2005028455A1 (pt) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1738610A (zh) * | 2003-01-22 | 2006-02-22 | 日绊株式会社 | 眼疾治疗用经皮吸收型制剂、其使用及眼疾治疗药向眼局部组织的转移方法 |
| PL2037967T3 (pl) | 2006-06-16 | 2017-07-31 | The Trustees Of The University Of Pennsylvania | Antagoniści receptora prostaglandyny D2 w leczeniu łysienia androgenowego |
| FR2903985B1 (fr) | 2006-07-24 | 2008-09-05 | Sanofi Aventis Sa | Derives de n-(amino-heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique |
| TWI410410B (zh) * | 2007-08-10 | 2013-10-01 | Ono Pharmaceutical Co | Phenylacetic acid compounds |
| DE102008059133A1 (de) | 2008-11-26 | 2010-05-27 | Merck Patent Gmbh | Difluorphenyl-diacylhydrazid-derivate |
| WO2016001452A1 (en) | 2014-07-04 | 2016-01-07 | Universität Zürich | Compounds, in particular for use in the treatment of a disease or condition for which a bromodomain inhibitor is indicated |
| RU2626829C2 (ru) * | 2015-11-02 | 2017-08-02 | Анатолий Тимофеевич Корабельников | Средство для лечения полипов в пазухах носа и для предотвращения их повторного нарастания, а также способ его применения |
| EP3854781B1 (en) | 2018-09-20 | 2024-05-22 | ONO Pharmaceutical Co., Ltd. | Dp antagonists |
| JP7088411B2 (ja) * | 2020-03-19 | 2022-06-21 | 小野薬品工業株式会社 | フェニル酢酸化合物の結晶 |
| JP7047954B2 (ja) * | 2020-03-19 | 2022-04-05 | 小野薬品工業株式会社 | フェニル酢酸化合物を含有する医薬組成物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5764655A (en) * | 1980-10-04 | 1982-04-19 | Nippon Zoki Pharmaceut Co Ltd | Novel benzoylaminophenylcarboxylic acid derivative, its preparation, and drug composition comprising it |
| WO1986005779A1 (en) * | 1985-04-03 | 1986-10-09 | Yamanouchi Pharmaceutical Co., Ltd. | Phenylene derivatives |
| JP4292742B2 (ja) * | 2000-03-09 | 2009-07-08 | 小野薬品工業株式会社 | インドール誘導体、その製造方法および用途 |
| RU2329256C2 (ru) | 2002-03-19 | 2008-07-20 | Оно Фармасьютикал Ко., Лтд. | Производное карбоновой кислоты, фармацевтическая композиция и средство для профилактики и/или лечения заболеваний, вызванных активацией dp-рецептора, применение производного карбоновой кислоты для производства такого средства, способ профилактики и/или лечения заболеваний, вызываемых активацией dp-рецепторов |
| AU2003227325B2 (en) * | 2002-08-02 | 2009-05-28 | Scientific Games, Llc | Lottery ticket security method |
| CN1764635A (zh) | 2003-02-07 | 2006-04-26 | 小野药品工业株式会社 | 羧酸化合物 |
| AU2004236248A1 (en) | 2003-04-30 | 2004-11-18 | The Institutes For Pharmaceutical Discovery, Llc | Phenyl substituted carboxylic acids |
-
2004
- 2004-09-16 DK DK04773373.8T patent/DK1666473T3/da active
- 2004-09-16 PT PT47733738T patent/PT1666473E/pt unknown
- 2004-09-16 TW TW093127979A patent/TWI341838B/zh not_active IP Right Cessation
- 2004-09-16 KR KR1020067005190A patent/KR20060080197A/ko not_active IP Right Cessation
- 2004-09-16 MX MXPA06002945A patent/MXPA06002945A/es active IP Right Grant
- 2004-09-16 EP EP04773373A patent/EP1666473B1/en active Active
- 2004-09-16 BR BRPI0414487-2A patent/BRPI0414487A/pt active Search and Examination
- 2004-09-16 PL PL04773373T patent/PL1666473T3/pl unknown
- 2004-09-16 AU AU2004274324A patent/AU2004274324B2/en not_active Ceased
- 2004-09-16 JP JP2005514124A patent/JP4919143B2/ja not_active Expired - Fee Related
- 2004-09-16 WO PCT/JP2004/013983 patent/WO2005028455A1/ja active Application Filing
- 2004-09-16 NZ NZ545934A patent/NZ545934A/en not_active IP Right Cessation
- 2004-09-16 US US10/572,578 patent/US7601712B2/en not_active Expired - Fee Related
- 2004-09-16 RU RU2006112573/04A patent/RU2375353C2/ru not_active IP Right Cessation
- 2004-09-16 ES ES04773373T patent/ES2399393T3/es active Active
- 2004-09-16 CA CA2539070A patent/CA2539070C/en not_active Expired - Fee Related
-
2006
- 2006-03-15 IL IL174336A patent/IL174336A/en not_active IP Right Cessation
- 2006-03-15 NO NO20061207A patent/NO20061207L/no not_active Application Discontinuation
-
2009
- 2009-09-01 US US12/551,860 patent/US8138335B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| NO20061207L (no) | 2006-06-19 |
| US8138335B2 (en) | 2012-03-20 |
| DK1666473T3 (da) | 2013-03-25 |
| JPWO2005028455A1 (ja) | 2006-11-30 |
| AU2004274324A1 (en) | 2005-03-31 |
| CA2539070A1 (en) | 2005-03-31 |
| WO2005028455A1 (ja) | 2005-03-31 |
| TWI341838B (en) | 2011-05-11 |
| NZ545934A (en) | 2009-05-31 |
| RU2006112573A (ru) | 2007-10-27 |
| IL174336A (en) | 2012-01-31 |
| EP1666473A4 (en) | 2009-06-03 |
| KR20060080197A (ko) | 2006-07-07 |
| US7601712B2 (en) | 2009-10-13 |
| US20100029631A1 (en) | 2010-02-04 |
| MXPA06002945A (es) | 2006-06-14 |
| EP1666473A1 (en) | 2006-06-07 |
| RU2375353C2 (ru) | 2009-12-10 |
| US20070004716A1 (en) | 2007-01-04 |
| EP1666473B1 (en) | 2013-01-02 |
| JP4919143B2 (ja) | 2012-04-18 |
| IL174336A0 (en) | 2006-08-01 |
| CA2539070C (en) | 2011-12-13 |
| TW200524886A (en) | 2005-08-01 |
| PL1666473T3 (pl) | 2013-05-31 |
| ES2399393T3 (es) | 2013-04-01 |
| AU2004274324B2 (en) | 2009-11-05 |
| BRPI0414487A (pt) | 2006-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0401963A3 (en) | Carboxylic acid derivative compounds and drugs comprising these compounds as the active ingredient | |
| IL174336A0 (en) | Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient | |
| PL372084A1 (en) | 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient | |
| PL370636A1 (en) | Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient | |
| IL164699A0 (en) | Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient | |
| HUP0501186A2 (en) | Pharmaceutical compositions comprising active vitamin d compounds | |
| IL157731A0 (en) | Caboxylic acid derivatives and pharmaceutical compositions containing the same | |
| AU2003239609A1 (en) | 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same | |
| EP1631239A4 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING ACTIVE COMPOUNDS OF VITAMIN D | |
| IL229510A0 (en) | A dosage form containing pantoprazole as an active ingredient | |
| IL174655A0 (en) | Drug containing (2r)-2-propyloctanoic acid as the active ingredient | |
| HK1105202A1 (en) | Heterocyclic compound and anti-malignant-tumor agent containing the same as active ingredient | |
| IL179336A0 (en) | Benzoic acid derivatives and pharmaceutical compositions containing the same | |
| IL174248A0 (en) | Alkyl carboxylic acid derivatives and pharmaceutical compositions containing the same | |
| AU2002309038A1 (en) | Compositions for transmucosal administration containing coenzyme Q as the active ingredient | |
| WO2004091591A3 (fr) | Composition nutritionnelle ou therapeutique contenant le compose oleurofeine ou l'un de ses derives | |
| IL174691A0 (en) | Infusion preparation containing (2r)-2-propyloctanoic acid as the active ingredient | |
| HUP0303636A3 (en) | Dihydronaphthalenederivative compounds and pharmaceutical compositions containing them as active ingredient | |
| HUP0303673A3 (en) | Piperidine derivatives and pharmaceutical compositions containing these derivatives as the active ingredient | |
| IL158172A0 (en) | Pharmaceutical compositions containing (-)-hydroxycitric acid | |
| IL172304A0 (en) | Pharmaceutical compositions comprising active vitamin d compounds | |
| IL161768A0 (en) | Carboxylic acid derivative compounds and drugs containing the same as the active ingredient | |
| EP1852119A4 (en) | PHARMACEUTICAL PREPARATION CONTAINING PHENOXAZINIUM DERIVATIVE AS ACTIVE INGREDIENT | |
| AU2002363776A1 (en) | Carboxylic acid derivative compounds and drugs containing the same as the active ingredient | |
| HUP0303714A3 (en) | Pharmaceutical compositions for dementia remedies containing 2-aryl-8-oxodihydropurine derivatives as the active ingredient |